2025 Volume 38 Issue 1 Pages 36-40
The prevalence of urolithiasis is increasing, making the selection of appropriate treatment strategies a critical issue in clinical practice. Extracorporeal Shock Wave Lithotripsy (ESWL) offers a minimally invasive option with significant advantages for suitable cases, including shorter hospital stays and lower complication rates. However, its effectiveness can vary depending on factors such as stone characteristics and patient-specific variables, leading to the necessity for retreatments in some cases. Conversely, Transurethral Lithotripsy (TUL) has gained prominence with higher single-treatment success rates but poses concerns regarding perioperative complications including infection and ureteral strictures. Recent updates in treatment guidelines and technological advancements have further refined the indications for ESWL, emphasizing the importance of accurate patient selection and the integration of innovative approaches. This review reevaluates the role of ESWL, exploring its current indications, factors influencing treatment success, and methodologies to optimize outcomes. By addressing these aspects, we aim to highlight the potential for ESWL to remain a viable and patient-friendly option in the evolving landscape of urolithiasis management.